MAVIRET
MAVIRET
Approved
DIN Number
02522470
Drug Class
Human
Market Date
Apr 22, 2022
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02522470
AIG Number0259390002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AP57 GLECAPREVIR AND PIBRENTASVIR
Product Specifications
Dosage FormGranules
Route of AdministrationOral
AHFS Classification08:18.40.24
Health Canada Classification
ACTIVE INGREDIENTS (2)
GLECAPREVIRActive
Strength: 50 MG / SACHET
Monograph: GLECAPREVIR
PIBRENTASVIRActive
Strength: 20 MG / SACHET
Monograph: PIBRENTASVIR